Literature DB >> 20808448

Human granulocytic anaplasmosis: First reported case in Canada.

Michael D Parkins1, Deirdre L Church, Xiu Yan Jiang, Daniel B Gregson.   

Abstract

Human granulocytic anaplasmosis (HGA) is a tick-borne rickettsial infection of peripheral blood neutrophils caused by Anaplasma phagocytophilum. While this infection is increasingly recognized as endemic throughout much of the United States, no Canadian cases have been previously described, despite the agent being identified in Canadian ticks. Herein we present a case of HGA acquired in an urban Alberta centre. Canadian physicians must be aware of the possibility of tick-borne rickettsial diseases as etiology of fever in individuals presenting with leukopenia/lymphopenia, thrombocytopenia and elevated transaminases during periods of tick activity. Prompt recognition and treatment are important in minimizing resultant morbidity and mortality.

Entities:  

Keywords:  Anaplasma phagocytophilum; Ehrlichia; Ixodes; Leukopenia; Thrombocytopenia; Ticks

Year:  2009        PMID: 20808448      PMCID: PMC2770309          DOI: 10.1155/2009/124173

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  16 in total

Review 1.  Tick-borne relapsing fever in North America.

Authors:  Mark S Dworkin; Tom G Schwan; Donald E Anderson
Journal:  Med Clin North Am       Date:  2002-03       Impact factor: 5.456

Review 2.  Clinical diagnosis and treatment of human granulocytotropic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

Review 3.  Lyme disease: a zoonotic disease of increasing importance to Canadians.

Authors:  N H Ogden; H Artsob; L R Lindsay; P N Sockett
Journal:  Can Fam Physician       Date:  2008-10       Impact factor: 3.275

4.  Ixodes scapularis ticks collected by passive surveillance in Canada: analysis of geographic distribution and infection with Lyme borreliosis agent Borrelia burgdorferi.

Authors:  N H Ogden; L Trudel; H Artsob; I K Barker; G Beauchamp; D F Charron; M A Drebot; T D Galloway; R O'Handley; R A Thompson; L R Lindsay
Journal:  J Med Entomol       Date:  2006-05       Impact factor: 2.278

Review 5.  Tularemia and Q fever.

Authors:  Elisa Choi
Journal:  Med Clin North Am       Date:  2002-03       Impact factor: 5.456

6.  Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals.

Authors:  Alice S Chapman; Johan S Bakken; Scott M Folk; Christopher D Paddock; Karen C Bloch; Allan Krusell; Daniel J Sexton; Steven C Buckingham; Gary S Marshall; Gregory A Storch; Gregory A Dasch; Jennifer H McQuiston; David L Swerdlow; Stephen J Dumler; William L Nicholson; David H Walker; Marina E Eremeeva; Christopher A Ohl
Journal:  MMWR Recomm Rep       Date:  2006-03-31

7.  Nosocomial transmission of human granulocytic anaplasmosis in China.

Authors:  Lijuan Zhang; Yan Liu; Daxin Ni; Qun Li; Yanlin Yu; Xue-jie Yu; Kanglin Wan; Dexin Li; Guodong Liang; Xiugao Jiang; Huaiqi Jing; Jing Run; Mingchun Luan; Xiuping Fu; Jingshan Zhang; Weizhong Yang; Yu Wang; J Stephen Dumler; Zijian Feng; Jun Ren; Jianguo Xu
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

Review 8.  Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment.

Authors:  J Stephen Dumler; John E Madigan; Nicola Pusterla; Johan S Bakken
Journal:  Clin Infect Dis       Date:  2007-07-15       Impact factor: 9.079

Review 9.  Human babesiosis.

Authors:  Edouard Vannier; Benjamin E Gewurz; Peter J Krause
Journal:  Infect Dis Clin North Am       Date:  2008-09       Impact factor: 5.982

Review 10.  Human granulocytic anaplasmosis and Anaplasma phagocytophilum.

Authors:  J Stephen Dumler; Kyoung-Seong Choi; Jose Carlos Garcia-Garcia; Nicole S Barat; Diana G Scorpio; Justin W Garyu; Dennis J Grab; Johan S Bakken
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

View more
  8 in total

1.  The prenylation inhibitor manumycin A reduces the viability of Anaplasma phagocytophilum.

Authors:  Qingming Xiong; Yasuko Rikihisa
Journal:  J Med Microbiol       Date:  2011-02-24       Impact factor: 2.472

2.  Human granulocytic anaplasmosis acquired from a blacklegged tick in Ontario.

Authors:  Stefan Edginton; T Hugh Guan; Gerald Evans; Siddhartha Srivastava
Journal:  CMAJ       Date:  2018-03-26       Impact factor: 8.262

Review 3.  Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases.

Authors:  Igor Dumic; Dorde Jevtic; Mladjen Veselinovic; Charles W Nordstrom; Milan Jovanovic; Vanajakshi Mogulla; Elmira Mofid Veselinovic; Ann Hudson; Gordana Simeunovic; Emilia Petcu; Poornima Ramanan
Journal:  Microorganisms       Date:  2022-07-15

4.  Case Report: Anaplasmosis in Canada: Locally Acquired Anaplasma phagocytophilum Infection in Alberta.

Authors:  William Stokes; Luiz F Lisboa; L Robbin Lindsay; Kevin Fonseca
Journal:  Am J Trop Med Hyg       Date:  2020-09-17       Impact factor: 3.707

Review 5.  Major emerging vector-borne zoonotic diseases of public health importance in Canada.

Authors:  Manisha A Kulkarni; Lea Berrang-Ford; Peter A Buck; Michael A Drebot; L Robbin Lindsay; Nicholas H Ogden
Journal:  Emerg Microbes Infect       Date:  2015-06-10       Impact factor: 7.163

6.  Recent Emergence of Anaplasma phagocytophilum in Ontario, Canada: Early Serological and Entomological Indicators.

Authors:  Mark P Nelder; Curtis B Russell; L Robbin Lindsay; Antonia Dibernardo; Nicholas C Brandon; Jennifer Pritchard; Steven Johnson; Kirby Cronin; Samir N Patel
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

Review 7.  The Impact of Tick-Borne Diseases on the Bone.

Authors:  Imran Farooq; Tara J Moriarty
Journal:  Microorganisms       Date:  2021-03-23

8.  A Case of Anaplasmosis during a Warm Minnesota Fall.

Authors:  Kushal D Khera; Danielle M Southerland; Nathaniel E Miller; Gregory M Garrison
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.